Amarachi Opara Hear my name
MD Student
Boston University Chobanian & Avedisian School of Medicine

Websites
favorite icon LinkedIn

ORCID ORCID Icon : 0009-0003-4286-4093



Amarachi “Amy” Opara knows firsthand what a debilitating disease does to a child and their family. From a young age, and continuing through high school and college, Opara (CAMED’29) assumed a large role with helping to care for her younger sister who has cerebral palsy and other developmental issues while her mother—a pharmacist originally from Nigeria—worked long hours to support the family.

“It’s what brought me to medicine,” Opara said. “It all stems from growing up with a sister with special needs.”

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Forrest SJ, Livingston JA, Vo KT, Glade Bender JL, Opara A, Smith S, Shah N, Chen N, London WB, Sweet-Cordero EA. Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma. Journal of Clinical Oncology. 2025; 3(16). View Publication
  2. Afolabi TA, Opara AO, Kareem SO, Oladoyinbo FO. In vitro digestibility of hydrothermally modified Bambara groundnut (Vigna subterranean L.) starch and flour. Food Sci Nutr. 2018 Jan; 6(1):36-46. PMID: 29387359
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 2017 and 2025

YearPublications
20171
20251

Contact for Mentoring: